×

Deadline in Lawsuit for Investors in Prosensa Holding NV (RNA) Shares Announced by Shareholders Foundation

SAN DIEGO, Sept. 8, 2014 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Prosensa Holding NV (RNA) over alleged Violations of Federal Securities Laws by Prosensa Holding NV.

If you purchased shares of Prosensa Holding NV (RNA), you have certain options and for certain investors are short and strict deadlines running. Deadline: September 16, 2014. Prosensa Holding NV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of investors who purchased Prosensa Holding NV (RNA) shares pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the "Registration Statement") issued in connection with the Company's initial public offering ("IPO") on or about June 28, 2013, that the defendants violated Federal Securities Laws. More specifically, the plaintiff alleges that the Registration Statement contained materially false and/or misleading statements and/or omitted material information concerning the development status of drisapersen, the drug's Phase II and Phase III clinical studies, and the prospects for drisapersen's regulatory approval.

On Sept. 20, 2013, GlaxoSmithKline and Prosensa Holding NV announced that the Phase III clinical study of drisapersen, an investigational antisense oligonucleotide, for the treatment of Duchenne Muscular Dystrophy patients with an amenable mutation, did not meet the primary endpoint of a statistically significant improvement in the 6 Minute Walking Distance test compared to placebo.

Shares of Prosensa Holding NV (RNA) dropped from $24.00 per share on Sept. 19, 2013, to as low as $3.60 per share on November 1, 2013.

Those who purchased shares of Prosensa Holding NV in the IPO have certain options and should contact the Shareholders Foundation, Inc. by e-mail at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108

Source:Shareholders Foundation, Inc.